MAGNESPASMYL 47.4 mg, film-coated tablet 50 tablets
Active ingredients: Magnesium, MAGNÉSIUM (LACTATE DE) DIHYDRATÉ
Commercialized according to BDPM
Film-coated tablet50 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MAGNESPASMYL 47,4 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 5 plaquette(s) thermoformée(s) PVC aluminium de 10 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES ETHYPHARM
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Mar 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67282578CIP73064408CIP133400930644089Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MAGNÉSIUM (LACTATE DE) DIHYDRATÉcomprimé | 465,4 mg · un comprimé | SA |
| MAGNÉSIUMcomprimé | 47,4 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.